AU2002334310A1 - 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders - Google Patents

1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders

Info

Publication number
AU2002334310A1
AU2002334310A1 AU2002334310A AU2002334310A AU2002334310A1 AU 2002334310 A1 AU2002334310 A1 AU 2002334310A1 AU 2002334310 A AU2002334310 A AU 2002334310A AU 2002334310 A AU2002334310 A AU 2002334310A AU 2002334310 A1 AU2002334310 A1 AU 2002334310A1
Authority
AU
Australia
Prior art keywords
pyrazoles
heterocyclyl
phenyl
treatment
inflammation associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002334310A
Inventor
Martha Lou Minich
Subas Man Sakya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of AU2002334310A1 publication Critical patent/AU2002334310A1/en
Abandoned legal-status Critical Current

Links

AU2002334310A 2001-11-02 2002-09-23 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders Abandoned AU2002334310A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/336,306 2001-11-02

Publications (1)

Publication Number Publication Date
AU2002334310A1 true AU2002334310A1 (en) 2003-05-12

Family

ID=

Similar Documents

Publication Publication Date Title
IL159771A0 (en) Combinations for the treatment of inflammatory disorders
AU2002356871A1 (en) Heteroaromatic carboxamide derivatives for the treatment of inflammation
AU2002341729A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2003220553A1 (en) Combination therapy for the treatment of conditions with pathogenic inflammatory components
AU2003225580A1 (en) Tricyclic pyrazole derivatives for the treatment of inflammation
AU2003206785A1 (en) Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
AU2003274342A1 (en) Compositions for the treatment of autoimmune disorders
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
AU2002338807A1 (en) Use of c-kit inhibitors for the treatment of myeloma
SI1627639T1 (en) Use of COX-2 inhibitors for the treatment of affective disorders
AU2003291719A1 (en) Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2003256650A1 (en) Substituted thiophene carboxamide compounds for the treatment of inflammation
AU2001253749A1 (en) 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
AU2001247233A1 (en) Ppar gamma agonists for the treatment of liver inflammatory disorders
AU2003220483A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU2003237460A1 (en) Combination treatments for purinoceptor-related disorders